Philip Böhler - Dissemin

Language
Login

All papers authored by Philip Böhler

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2024 Philip Böhler

ORCID

, Philip Böhler

Palopegteriparatid (chronischer Hypoparathyreoidismus); Nutzenbewertung gemäß § 35a SGB V

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Philip Böhler

ORCID

Inadequate subsequent therapies in oncology trials – consequences for interpreting overall survival

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 Philip Böhler

ORCID

, Philip Böhler

Lisocabtagene maraleucel (DLBCL, HGBCL, PMBCL and FL3B, each after one prior therapy) – Benefit assessment

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Philip Böhler

ORCID

, Philip Böhler

Trastuzumab deruxtecan (gastric cancer) – Benefit assessment

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2022 Philip Böhler

ORCID

, Philip Böhler

Palbociclib (breast cancer) – Benefit assessment

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Philip Böhler

ORCID

, Philip Böhler

Empagliflozin (heart failure) - Benefit assessment

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Philip Böhler

ORCID

, Philip Böhler

Duvelisib (follicular lymphoma) - Benefit assessment

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Philip Böhler

ORCID

, Philip Böhler

Duvelisib (chronic lymphocytic leukaemia) - Benefit assessment

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Philip Böhler

ORCID

, Philip Böhler

Pembrolizumab (oesophageal cancer) - Benefit assessment

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2021 Philip Böhler

ORCID

, Philip Böhler

Daratumumab (multiple myeloma) - Benefit assessment

Upload

This paper is made freely available by the publisher.

Jana Deitersen

ORCID

, Lena Berning, Fabian Stuhldreier, Sara Ceccacci

ORCID

, David Schlütermann, Annabelle Friedrich, Wenxian Wu

ORCID

, Yadong Sun, Philip Böhler

ORCID

, Niklas Berleth, María José Mendiburo

ORCID

, Sabine Seggewiß, Ruchika Anand

ORCID

, Andreas S. Reichert

ORCID

, Maria Chiara Monti

ORCID

and 2 other authors

High-throughput screening for natural compound-based autophagy modulators reveals novel chemotherapeutic mode of action for arzanol

Download from www.nature.com

This paper is made freely available by the publisher.

2020 Wenxian Wu, Xiaojing Wang, Niklas Berleth, Jana Deitersen, Nora Wallot-Hieke, Philip Böhler

ORCID

, David Schlütermann, Fabian Stuhldreier, Jan Cox, Katharina Schmitz, Sabine Seggewiß, Christoph Peter, Gary Kasof, Anja Stefanski, Kai Stühler and 3 other authors

The Autophagy-Initiating Kinase ULK1 Controls RIPK1-Mediated Cell Death

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2019 Philip Böhler

ORCID

Three Tales of Death: New Pathways in the Induction, Inhibition and Execution of Apoptosis

Upload

This paper was not found in any repository, but could be made available legally by the author.

2018 David Schlütermann, Margaretha A. Skowron, Niklas Berleth, Philip Böhler

ORCID

, Jana Deitersen, Fabian Stuhldreier, Nora Wallot-Hieke, Wenxian Wu, Christoph Peter, Michèle J. Hoffmann, Günter Niegisch, Björn Stork

Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex

Upload

This paper is made freely available by the publisher.

Philip Böhler

ORCID

, Fabian Stuhldreier, Ruchika Anand

ORCID

, Arun Kumar Kondadi, David Schlütermann, Niklas Berleth, Jana Deitersen, Nora Wallot-Hieke, Wenxian Wu, Marian Frank, Hendrik Niemann, Elisabeth Wesbuer, Andreas Barbian, Tomas Luyten, Jan B. Parys

ORCID

and 10 other authors

The mycotoxin phomoxanthone A disturbs the form and function of the inner mitochondrial membrane

Download from www.nature.com

This paper is made freely available by the publisher.

2017 Alexander Lang, Ruchika Anand

ORCID

, Simone Altinoluk-Hambüchen, Hakima Ezzahoini, Anja Stefanski, Afshin Iram, Laura Bergmann, Jennifer Urbach, Philip Böhler

ORCID

, Jan Hänsel, Manuel Franke, Kai Stühler, Jean Krutmann, Jürgen Scheller, Björn Stork and 2 other authors

SIRT4 interacts with OPA1 and regulates mitochondrial quality control and mitophagy

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2016 Philip Böhler

ORCID

The mycotoxin Phomoxanthone A damages the inner mitochondrial membrane

Upload

This paper is made freely available by the publisher.

Marta Czugala, Olga Mykhaylyk, Philip Böhler

ORCID

, Jasmine Onderka, Björn Stork, Sebastian Wesselborg, Friedrich E. Kruse, Christian Plank, Bernhard B. Singer, Thomas A. Fuchsluger

Efficient and safe gene delivery to human corneal endothelium using magnetic nanoparticles

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2015 Marian Frank, Hendrik Niemann, Philip Böhler

ORCID

, Björn Stork, Sebastian Wesselborg, Wenhan Lin, Peter Proksch

Phomoxanthone A - From Mangrove Forests to Anticancer Therapy

Upload

Missing publications? Search for publications with a matching author name.